11 APRIL 2018
14 APRIL 2018
We are excited to announce that we will be at the 2018 American College of Medical Genetics (ACMG) Annual Meeting this year! Please stop by booth #402 to discuss the following topics:
- Our integrated Roche Sample Prep Solution which encompasses all the steps required to convert a sample to a sequencing-ready library. From sample collection to library quantification, we offer sample prep solutions for different, as well as challenging, sample types and sequencing applications that are proven, complete and simple.
- New SeqCap EZ Design Share panels,* which include our new hereditary cardiology research panels that cover over 140 genes and regions associated with cardiovascular diseases.
In addition, we invite you to join us at the following presentation:
- The Harmony® prenatal test Product Theater “Non-invasive prenatal testing (NIPT) for 22q11.2 deletion syndrome.”
Thursday, April 12, 2018, 12:15 pm – 12:45 pm Theater #1
NIPT for 22q11.2 deletion syndrome has been offered commercially since 2013. However, published validation data is extremely limited. The session will give an overview on the available evidence and discuss implications for clinical practice.
If you are not attending ACMG and would like to learn more about these topics, please contact your local sales representative.
*Research Use Only. Not for use in diagnostic procedures.
SeqCap is a trademark of Roche. All other product names and trademarks are the property of their respective owners.
The Harmony prenatal test was developed, and its performance characteristics determined by Ariosa Diagnostics, Inc., a CLIA-certified and CAP-accredited clinical laboratory in San Jose, CA USA. This testing service is a laboratory developed test and has not been cleared or approved by the US FDA. HARMONY and HARMONY and Design are trademarks of Ariosa Diagnostics, Inc. in the US. HARMONY is a trademark of Roche in other countries. All other product names and trademarks are the property of their respective owners.